Clinical Trial Update: Combination Nicotine Replacement Therapy, Cytisine, or Varenicline for Smoking Cessation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating combinations of nicotine replacement therapy, cytisine, or varenicline for smoking cessation is currently recruiting. Sponsor:…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Use Disorder

Drugs mentioned

• Nicotine replacement therapy (nicotine replacement therapy)
• Varenicline (varenicline)
• cytisine (cytisine)

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Tobacco | Phase 4 | Status: RECRUITING